Dr. Brian Baker, D.O

NPI: 1922459015
Total Payments
$1,291
2020 Payments
$99.77
Companies
12
Transactions
19
Medicare Patients
3,304
Medicare Billing
$317,374

Payment Breakdown by Category

Food & Beverage$1,291 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,291 19 100.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $316.28 4 $0 (2020)
PORTOLA PHARMACEUTICALS, LLC $152.64 2 $0 (2020)
AstraZeneca Pharmaceuticals LP $131.82 3 $0 (2020)
Valeant Pharmaceuticals North America LLC $111.89 2 $0 (2017)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $102.25 1 $0 (2019)
The Medicines Company $93.74 1 $0 (2017)
Melinta Therapeutics, Inc. $92.63 1 $0 (2018)
Philips Electronics North America Corporation $79.49 1 $0 (2018)
Chiesi USA, Inc. $60.39 1 $0 (2018)
Janssen Pharmaceuticals, Inc $58.73 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2020 $99.77 4 E.R. Squibb & Sons, L.L.C. ($52.06)
2019 $596.29 7 PORTOLA PHARMACEUTICALS, INC. ($130.81)
2018 $232.51 3 Melinta Therapeutics, Inc. ($92.63)
2017 $362.17 5 E.R. Squibb & Sons, L.L.C. ($156.54)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/24/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $12.94 General
Category: Cardiovascular and Metabolism
03/31/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $12.94 General
Category: Cardiovascular and Metabolism
02/20/2020 PORTOLA PHARMACEUTICALS, LLC ANDEXXA (Biological) Food and Beverage Cash or cash equivalent $21.83 General
Category: HEMATOLOGY/NEUROLOGY
02/13/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $52.06 General
Category: Cardiovascular
11/14/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $102.25 General
Category: GASTROENTEROLOGY
09/12/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $105.94 General
Category: Cardiovascular and Metabolism
08/08/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $47.75 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/11/2019 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $107.68 General
Category: Cardiovascular
04/11/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $58.73 General
Category: Cardiovascular & Metabolism
02/13/2019 PORTOLA PHARMACEUTICALS, INC. ANDEXXA (Biological) Food and Beverage In-kind items and services $130.81 General
Category: HEMATOLOGY/NEUROLOGY
01/10/2019 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $43.13 General
Category: GIAPREZA
09/13/2018 Chiesi USA, Inc. CLEVIPREX (Drug) Food and Beverage Cash or cash equivalent $60.39 General
Category: CARDIOVASCULAR
07/12/2018 Melinta Therapeutics, Inc. Orbactiv (Drug) Food and Beverage Cash or cash equivalent $92.63 General
Category: INFECTIOUS DISEASES
02/08/2018 Philips Electronics North America Corporation IGT_D Peripheral (Device) Food and Beverage Cash or cash equivalent $79.49 General
Category: Cardiology/Vascular Diseases
11/16/2017 Valeant Pharmaceuticals North America LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.50 General
Category: GASTROENTEROLOGY
10/11/2017 Valeant Pharmaceuticals North America LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $99.39 General
Category: GASTROENTEROLOGY
07/13/2017 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $58.49 General
Category: Cardiovascular
04/12/2017 The Medicines Company MINOCIN IV (Drug), ORBACTIV Food and Beverage In-kind items and services $93.74 General
Category: INFECTIOUS DISEASE
03/08/2017 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $98.05 General
Category: Cardiovascular

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 793 828 $985,689 $71,853
2022 5 772 815 $881,718 $64,122
2021 6 1,081 1,168 $1.3M $98,077
2020 5 658 687 $1.1M $83,322
Total Patients
3,304
Total Services
3,498
Medicare Billing
$317,374
Procedure Codes
21

All Medicare Procedures & Services

21 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 368 386 $707,689 $51,107 7.2%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 150 154 $187,378 $13,893 7.4%
99283 Emergency department visit with low level of medical decision making Facility 2023 57 57 $41,967 $3,130 7.5%
99291 Critical care, first 30-74 minutes Facility 2023 15 15 $32,425 $2,418 7.5%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 203 216 $16,230 $1,306 8.0%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 284 297 $572,168 $41,137 7.2%
99284 Emergency department visit for problem of high severity Facility 2022 105 110 $139,205 $10,019 7.2%
99291 Critical care, first 30-74 minutes Facility 2022 40 42 $91,845 $7,212 7.9%
99283 Emergency department visit for problem of moderate severity Facility 2022 74 74 $57,038 $3,918 6.9%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 269 292 $21,462 $1,835 8.6%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 357 391 $767,338 $54,425 7.1%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 106 111 $243,756 $20,153 8.3%
99284 Emergency department visit, problem of high severity Facility 2021 157 162 $208,326 $15,105 7.3%
99283 Emergency department visit, moderately severe problem Facility 2021 75 76 $61,540 $4,158 6.8%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 370 409 $29,050 $2,564 8.8%
99292 Critical care delivery critically ill or injured patient Facility 2021 16 19 $19,134 $1,673 8.7%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 291 312 $613,241 $43,831 7.1%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 115 118 $251,282 $22,067 8.8%
99284 Emergency department visit, problem of high severity Facility 2020 133 138 $178,236 $12,982 7.3%
99283 Emergency department visit, moderately severe problem Facility 2020 89 89 $66,124 $4,267 6.5%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2020 30 30 $1,798 $175.52 9.8%

About Dr. Brian Baker, D.O

Dr. Brian Baker, D.O is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1922459015.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Baker, D.O has received a total of $1,291 in payments from pharmaceutical and medical device companies, with $99.77 received in 2020. These payments were reported across 19 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,291).

As a Medicare-enrolled provider, Baker has provided services to 3,304 Medicare beneficiaries, totaling 3,498 services with total Medicare billing of $317,374. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location Oklahoma City, OK
  • Active Since 06/29/2016
  • Last Updated 06/29/2016
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1922459015

Products in Payments

  • ELIQUIS (Drug) $364.03
  • ANDEXXA (Biological) $152.64
  • LOKELMA (Drug) $131.82
  • XIFAXAN (Drug) $111.89
  • RELISTOR (Drug) $102.25
  • MINOCIN IV (Drug) $93.74
  • Orbactiv (Drug) $92.63
  • IGT_D Peripheral (Device) $79.49
  • CLEVIPREX (Drug) $60.39
  • XARELTO (Drug) $58.73
  • GIAPREZA (Drug) $43.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Oklahoma City